VeriChip Hopes To Round Up More Micro-Chip Implantees

2 views
Skip to first unread message

Pastor Dale Morgan

unread,
Mar 29, 2007, 11:57:56 PM3/29/07
to Bible-Pro...@googlegroups.com
*Big Brother and The Mark of The Beast


VeriChip Hopes To Round Up More Micro-Chip Implantees *


Added: Mar 29th, 2007 8:32 AM

VeriChip to Present at American Medical Directors Association Annual
Symposium on March 29-30, 2007

Thursday March 29, 8:30 am ET


DELRAY BEACH, Fla., March 29 /PRNewswire-FirstCall/ -- VeriChip
Corporation (Nasdaq: CHIP - News), a provider of RFID systems for
healthcare and patient-related needs, will present at the American
Medical Directors Association (AMDA) 30th Annual Symposium in Hollywood,
Florida, on March 29- 30, 2007. The conference attracts over 4000
medical directors, attending physicians, nurses, administrators,
consultant pharmacists and other long-term care professionals. VeriChip
expects to enroll additional physicians in its VeriMed Patient
Identification System network through the symposium. Presenting on
behalf of VeriChip is AMDA Foundation Chair and former AMDA President
Jonathan Musher, MD, CMD.

AMDA is the professional association of medical directors and physicians
practicing in the long term care continuum dedicated to excellence in
patient care by providing education, advocacy, information, and
professional development.

About VeriChip Corporation

VeriChip Corporation, headquartered in Delray Beach, Florida, develops,
markets and sells radio frequency identification, or RFID, systems used
to identify, locate and protect people and assets. VeriChip's goal is to
become the leading provider of RFID systems for people in the healthcare
industry. VeriChip sells passive RFID systems for identification
purposes and active RFID systems for local-area location and
identification purposes. VeriChip recently began to market its
VeriMed(TM) Patient Identification System for rapidly and accurately
identifying people who arrive in an emergency room and are unable to
communicate. This system uses the first human-implantable passive RFID
microchip, the implantable VeriChip(TM), cleared for medical use in
October 2004 by the United States Food and Drug Administration.

VeriChip Corporation is majority-owned by Applied Digital Inc. (Nasdaq:
ADSX - News), which also owns a majority position in Digital Angel
Corporation (Amex: DOC - News). For more information on VeriChip, please
call 1-800-970- 2447, or email in...@verichipcorp.com. Additional
information can be found online at http://www.verichipcorp.com.

Statements about the Company's future expectations, including future
revenues and earnings, and all other statements in this press release
other than historical facts are "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, Section 21E of the
Securities Exchange Act of 1934, and as that term is defined in the
Private Litigation Reform Act of 1995. Such forward-looking statements
involve risks and uncertainties and are subject to change at any time,
and the Company's actual results could differ materially from expected
results. The Company undertakes no obligation to update forward-looking
statements to reflect subsequently occurring events or circumstances.

Reply all
Reply to author
Forward
0 new messages